Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conjuran vs Hyruan Plus for pain improvement in knee osteoarthritis
KCT0008003Phase 4Completed
- Sponsor
- PharmaResearch
- Start
- Dec 2019
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of polynucleotide sodium, Hyruan Plus in knee osteoarthritis (OA), sponsored by PharmaResearch. Started Dec 2019; status: completed.
02
Drugs
polynucleotide sodiumHyruan Plus
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on KCT0008003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008003.